JP Morgan Raises Globe Life (GL) Price Target to $195

JP Morgan has boosted its price target for Globe Life Inc. to $195, a 16.42% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:28 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

JP Morgan raised its price target on Globe Life Inc. ($GL) to $195 from $193 on October 15, 2026, and rates the stock "Overweight".

Since the rating, $GL is up 0.7% to date (from the $167.59 close on Oct 15, 2026).

GL Globe Life Inc.

$168.77 +22.92% year to date

Daily close · Oct 16, 2026

Key Points

JP Morgan has reiterated an Overweight rating on Globe Life Inc. and raised its price target to $195 from $193.
Globe Life shares are currently trading at $167.5, below the new target, suggesting potential upside.
The company has a market cap of about $13.23 billion and a P/E ratio of 11.4.

Get $GL trade alerts by text

We text you when insiders, Congress or big funds trade $GL. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Globe Life Inc. alert may contain errors. Disclosures

JP Morgan has reiterated its Overweight rating on Globe Life Inc. (NYSE: GL) and increased its price target to $195 from $193. The rating update was made on October 15, 2026, as shares are currently priced at $167.5.

Analyst rating track record

JP Morgan vs. the S&P 500

YTD return -1.44% hypothetical

All-time return -1.44% S&P 500 +0.45%

vs. S&P 500 -1.89% behind the index

Hypothetical returns from JP Morgan's disclosed trades, not real profit or advice. How we model this.

JP Morgan's Call on Globe Life

JP Morgan's new price target reflects a positive outlook on Globe Life, which provides various life and supplemental health insurance products. The stock had closed at $173.42 prior to the update, indicating a potential upside for investors.

Other Institutional Activity in Globe Life

Several other institutional investors have recently changed their positions in Globe Life. Blackrock Inc. trimmed its holdings by 13,857 shares, leaving them with approximately 5.53 million shares valued at around $927.6 million. Vanguard Capital Management LLC reduced its stake by 69,007 shares, ending with about 5.08 million shares worth about $852.4 million. Conversely, Invesco Ltd. increased its holdings by 602,856 shares, bringing its total to about 4.62 million shares valued at approximately $775 million, a 15% increase. State Street Corporation also added 76,830 shares to its position, now holding around 3.74 million shares worth about $626.7 million.

Globe Life Inc. Stock Down 3.4%

Currently, Globe Life shares are trading below their recent highs, with a 52-week range between $127.85 and $191.55. The stock is currently well-positioned relative to the 50-day moving average of $177.17, which could suggest a period of volatility as it approaches earnings.

12-month forecast

$GL price target

Globe Life Inc. daily closes and this analyst's $195 target. Not advice.

Recent Earnings

In its most recent earnings report, Globe Life generated revenue of approximately $6.19 billion, reflecting an 8% growth. The company reported earnings per share (EPS) of $15.04 and maintains a net margin of about 19.6%. The next earnings report is scheduled for October 21, 2026.

Insider Buying and Selling at Globe Life Inc.

Insider selling activity includes several significant transactions. On September 22, 2026, Chief Investment Officer Hensley Robert Edward sold 10,000 shares valued at about $1.7 million. CEO Darden James Matthew sold 50,000 shares on July 31, 2026, totaling around $9.1 million. CFO Kalmbach Thomas Peter sold 21,000 shares for approximately $3.78 million on July 30, 2026. Additionally, Officer Majors Michael Clay sold 37,000 shares for about $6.61 million on July 29, 2026.

Analysts Set New Price Targets

On October 15, 2026, JP Morgan maintained its Overweight rating on Globe Life with a target price of $195. Wells Fargo also maintained an Overweight rating with a target of $191, while Morgan Stanley kept its Overweight rating but lowered the target to $197 from $208. Overall, the consensus target among analysts is approximately $193.91, with 11 analysts providing opinions on the stock.

About Globe Life

Globe Life Inc. provides various life and supplemental health insurance products aimed primarily at lower middle- and middle-income families in the United States. Its operations are divided into three main segments: Life Insurance, Supplemental Health Insurance, and Investments. The company's latest analyst updates reflect a strong position within the financial services sector.

Bottom Line

Investors will want to watch Globe Life closely as it prepares to report its earnings on October 21, 2026. JP Morgan's updated rating and target suggest a positive outlook, but the backward-looking nature of the 13F filings means positions may change as new data comes in.